Overview
Richard Lovell practices in Birmingham, United Kingdom. Mr. Lovell is rated as an Advanced expert by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His top areas of expertise are Acute Monoblastic Leukemia (AmoL), Graft Versus Host Disease (GvHD), Autoimmune Hemolytic Anemia, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
His clinical research consists of co-authoring 14 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Acute Monoblastic Leukemia (AmoL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Monoblastic Leukemia (AmoL)Mr. Lovell isAdvanced. Learn about Acute Monoblastic Leukemia (AmoL).
- Bone Marrow TransplantMr. Lovell isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Lovell isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Autoimmune Hemolytic AnemiaMr. Lovell isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Graft Versus Host Disease (GvHD)Mr. Lovell isExperienced. Learn about Graft Versus Host Disease (GvHD).
- LeukemiaMr. Lovell isExperienced. Learn about Leukemia.